Abstract Submission

Abstract submissions for IADR-APR is now closed!

Submission closes at midnight, Pacific time.

The Scientific Program Committee welcomes the submission of abstracts for the 4th Asia Pacific Region Congress of the International Association for Dental Research (IADR-APR 2019) to be held at the Brisbane Convention and Exhibition Centre, Queensland, Australia from 28 – 30 November 2019. The IADR-APR 2019 meeting will provide scientists and researchers throughout the Asia-Pacific region with the opportunity to present, discuss and critique their investigations. If you are involved in dental, oral and craniofacial research, we urge you to submit an abstract for presentation consideration. The oral and poster sessions will be designed around accepted abstracts.


Key Dates

15 April 2019 Abstract on-line submission site opens
08 July 2019 Extended deadline to submit an abstract to system
07 August 2019 Author notified of abstract submission outcome
28 August 2019 Author registration deadline



Step 1: Click the ‘Submit Abstract’ button to commence your submission where it appears online on the official IADR-APR 2019 Meeting website, https://iadr-apr2019.com.

Step 2: You will be directed to the submission site to create an account. Once an account is created, please verify the account by clicking on the link provided via the account verification email sent to your nominated email address.

Step 3: Log in to your account after it has been verified using your email address as username and nominated password.
Click on the ‘Submit Abstract’ button to begin submitting your abstract.

Step 4: Type the title of your abstract in the ‘Abstract Title’ field and upload the body only of your abstract as a file in .doc. or .docx. format. A template is available here. Do not repeat the title or author(s) details in the body of your abstract text.

Authors will be able to edit their profile, which was generated when an author account was created, by clicking on the ‘edit’ button under the Author(s) field section.

Complete all other required fields.

Please direct any questions to the IADR-APR 2019 Meeting Managers at iadr-apr2019@arinex.com.au

Abstract Submission

The IADR-APR 2019 Program Committee welcomes your abstract submission.

Abstract Rules and Guidelines

  1. Individuals may present only one abstract (excluding Symposia, Hands-on Workshops, Lunch & Learning and Keynote Speakers).
  2. Projects being reported must be original research.
  3. Submitters may NOT split one study into several papers.
  4. Individuals can co-author multiple abstracts.
  5. Presenters must disclose any personal or co-author potential conflict of interest and agree to the IADR Policy on Full Disclosure along with the IADR Abstract Licensing Policy during submission.
  6. Previously published abstracts (in print or any electronic format) or those presented at another meeting are not allowed.
  7. Abstracts should not be submitted on material that will also be presented at a symposium held at the same meeting.
  8. Authors of presentations later proven to contain previously published or presented material will be sanctioned and may be prohibited from presenting at future meetings.
  9. The Scientific Program Committee (SPC) reserves the right to reclassify submitted abstracts into the most appropriate area of review.
  10. Abstracts must be submitted via the online abstract submission site. Faxes, photocopies or emailed copies will not be reviewed.
  11. You must receive the approval of all co-authors before including their names on the abstract.
  12. There will not be an option for Late-Breaking News Abstracts.
  13. There will not be an abstract replacement period.
  14. Abstracts will be reviewed as submitted by the abstract deadline of 1 July 2019. Presenters are not permitted to modify their abstracts after this date.

All presenters must agree to the following conditions when submitting an abstract:

  1. Affirm that any work with human or animal subjects reported in the abstract complies with the guiding principles for experimental procedures found in the Declaration of Helsinki of the World Medical Association, and the research project has been duly cleared by an Institutional Review Board (IRB) or Institutional Ethics Committee or an equivalent ethical body.
  2. Affirm that the work has not been published (in print or electronically) or presented elsewhere prior to the IADR-APR 2019 Meeting.
  3. Agree that if the abstract is accepted, IADR has permission to publish the abstract in printed and/or electronic formats.
  4. Agree to pre-register for the meeting and pay the appropriate registration fee by the presenter pre-registration deadline of 28 August 2019.

    Failure to pre-register by 28 August 2019 will result in the following:

  • The abstract will be automatically withdrawn from the Program Book and the Online Abstract System.
  • The submitter will not be allowed to present their abstract at the
  • The abstract will not be citable as being part of the Special Issue of the Journal of Dental Research.

By submitting an abstract to IADR, and in consideration for the opportunity to be included in IADR’s presentations, the author of the abstract hereby provides to IADR a non-exclusive, irrevocable, worldwide, royalty-free license to use the abstract in IADR’s publications and materials. To the extent that IADR incorporates an abstract in a collection or compilation of materials, including but not limited to any publication of meeting abstracts or an online, searchable collection of abstracts, the author acknowledges and agrees that IADR shall own all right, title and interest in and to such collections and compilations including any copyrights to said collections and compilations. Notwithstanding the foregoing, U.S. Government Works, as defined under the Copyright Act found under Title 17 of the U.S. Code, are exempt from any copyright transfer contemplated herein, and any purported transfer of the copyright to a U.S. Government Work pursuant to this subsection shall be of no force or effect.

IADR seeks to provide participants in its education sessions with current, scientifically-based information relevant to dental, oral and craniofacial research, the practice of dentistry and the oral health of the public. Once a presenter is selected for a particular topic, IADR makes no attempt to control the content of the presentation or the content of any submitted abstract. Therefore, in submitting an abstract for presentation and publication, a presenter represents and warrants to IADR that any intellectual property associated with or contained in the content of the abstract or presentation is owned by the presenter or the presenter is authorized to use said content along with any applicable intellectual property associated with the content.

A presenter may be required by IADR to provide adequate written assurance that the presenter is authorized to use the content of the abstract or presentation. In the event IADR requests such written assurance and the presenter fails to provide the requested documentation, the presenter may be denied the ability to make the presentation. For any abstract or presentation, the presenter and any applicable co-authors of the content must be identified by full name and any affiliation. The presenter also has received the approval from the co-author(s) to have their name(s) associated with the abstract and its content prior to submission.

The presenter further agrees to indemnify and hold harmless IADR from any and all claims of third parties regarding the content of the abstract or presentation, including but not limited to any claims of infringement of intellectual property or misappropriation of proprietary or trade secret information.

In order to ensure fairness to the audience and the public, however, IADR requires each presenter and co-authors to disclose:

  1. Any financial relationship between the presenter and co-authors and
    1. A company that manufactures or distributes a product discussed in the presentation, or
    2. A company whose product competes, or may compete, with a product discussed in the presentation must be disclosed to the IADR upon approval on the abstract form and must be disclosed to the audience at the beginning of the

As used in this document, “financial relationship” includes a consulting arrangement or the conduct or research for the company by the presenter or co-author or a member of the presenter’s or co-author’s immediate family. It also includes ownership of stock or other interest in a company by the presenter or co-author, and/or a trust of which the presenter, co-author, or a member of the presenter’s or co-author’s immediate family is a beneficiary, to the best knowledge of the presenter.

  1. All presentations must be made in a professional manner, without disparaging colleagues, companies or products. Unnecessarily demeaning comments and attacks on colleagues, companies or products are unacceptable.

Failure to adhere to these guidelines may result in sanctions as deemed appropriate by the IADR, including denial of permission to present at future IADR meetings.

If you are unable to attend the meeting and wish to name a substitute presenter, please use the following guidelines:

  • The Presenting Author is the only author that may request a presenter change.
  • Substitute presenter must be a co-author.
  • Substitute presenter must NOT be presenting another abstract at the meeting.
  • After the abstract submission deadline of 1 July 2019, all requests for presenter changes MUST be made using the ‘Contact Meeting Manager’ function via the abstract submission portal.
  • Substitution requests must be made PRIOR to the meeting.
  • All Presenter Changes must be communicated to and approved by the IADR-APR 2019 Scientific Program Committee prior to the scheduled presentation.
  • Failure to follow the above procedures may result in the presenter being charged the full registration fee and/or not being allowed to present at a future meeting.

The following are the guidelines for withdrawing abstracts:

  • You may withdraw your abstract at any time until 1 July 2019, without notifying IADR, through the abstract submission
  • Abstracts withdrawn after 1 July 2019, must be withdrawn using the ‘Contact Meeting Manager’ function via the abstract submission portal. Requests not submitted via the portal will not be
  • Withdrawal requests must be received PRIOR to the
  • Lack of travel funds is NOT an acceptable excuse for withdrawing an abstract from the
  • Failure to follow the above procedures may result in the presenter being charged the full registration fee and/or not being allowed to present at a future

PLEASE NOTE: Any submitted abstract that does not contain text, or is still in draft, will be withdrawn automatically after 1 July 2019. No changes to abstract text including correcting typographical errors, incorrect data, etc. will be permitted after 1 July 2019.



 All abstracts must be submitted online via the IADR online abstract submission portal. Each completed submission is reviewed for its scientific content by the Scientific Program Committee.


Important Submission Elements


  1. Scientific Group/Network: All abstracts must be submitted to an appropriate Scientific Group/Network category for review based on the scientific content of the abstract. A large majority of abstracts are transferred each year. If you select the appropriate area, you are more likely to be graded by peers with similar interests and who are familiar with you and your research topic. See the appropriate section below for a complete listing of Scientific Groups/Networks.
  2. Titles: Abstract titles are limited to 10 words or less. The title should be dynamic and conclusive, rather than descriptive, and should be entered in title case format, AP format. In general, you should capitalize the first letter of each word unless it is a preposition or article. Do italicize scientific names of organisms such as Streptococcus or Titles should not be in bold font.
  3. Authors: Each author should be added separately to the submission to ensure proper listing. Enter first (given) name, and last (family/surname) name for each author, contact details plus institution/affiliation. Please do not list the department/branch in the institution/affiliation field. One person must be identified as the presenting author. The order of the authors can be modified at any time prior to the abstract deadline.
  4. Abstract Text: All abstracts should be 300 words or less. Do not include your title or authors in the abstract text — these items will be collected separately. Do not include references. If the abstract is based on research that was funded entirely or partially by an outside source, then be sure to enter the appropriate information (funding agency and grant number if applicable) when prompted during submission. You do not need to re-enter the information with your abstract text. However, all external funding MUST also be acknowledged in the presentation if accepted. Tables are permitted but should be simple and concise. Graphics/images are not recommended unless they are integral to the abstract and should be limited to no more than one or two.
  5. Special Characters: Special characters in the title or body of the abstract or in the co-author’s names or affiliations should be entered into the system using formatting functions in the submission system to avoid formatting errors.
  6. Content of the Abstract: Titles, authors and authors’ affiliations are not included in the 300-word limit (references are not collected by IADR). The abstract must contain a brief statement of:
    1. The objectives of the investigation,
    2. Experimental methods used,
    3. Essential results, including data and, where appropriate, statistics,
    4. Conclusion
  7. Other Items: the following information should be submitted:
  • Keywords: All abstract submissions may select up to five keywords from a list. A minimum of two keywords are required. Keywords should be selected from Medical Subject Headings (MeSH) to be used for indexing of articles. See: http://www.nlm.nih.gov/mesh/MBrowser.html for information on the selection of key
  • Educator/Clinician Track: IADR will ask if your research fits well into one of the tracks created by the ASC. Selecting the Educator track indicates content would be of most interest to educators. Selecting the Clinician track indicates content would be of most interest to
  • Contact Information: IADR will only correspond with the presenting author listed on the abstract regardless of who may have submitted the abstract. Thus, make sure to include a correct email address/phone number for the presenting author. If the presenting author relocates before the IADR-APR 2019, please be sure to notify the Meetings Managers with the your new details.
  • Chair Opportunities: Be prepared to enter whether or not the presenter is interested in serving as an Oral Session Chair or Poster Session Chair. Abstract presenters accepted into oral sessions are automatically entered into consideration for

IADR will accept the submission of Systematic Review Abstracts. Systematic Reviews are defined as, “a review of a clearly formulated question that uses systematic and explicit methods to identify, select and critically appraise relevant research, and to collect and analyse data from the studies that are included in the review. Statistical methods (meta-analysis) may or may not be used to analyse and summarize the results of the included studies. The aim is to ensure a review process that is comprehensive and unbiased. Findings from systematic reviews may be used to determine research priorities and/or provide the scientific basis for clinical treatment.”

  • Failure to state objective and conclusion.
  • Failure to state sample size and data.
  • Excessive use of abbreviations.
  • Excessive use of commercial product names.
  • Typographical errors (authors can’t change any text after the abstract deadline).
  • Writing your abstract at the last minute.
  • Work that is duplicative is not well received and you will only be asked to combine with another abstract or your abstract may not be accepted.

Make sure to show your abstract to a colleague prior to submission to avoid making common mistakes.

Some research collaborations with large numbers of investigators, operating under a single group name, request the inclusion of the group name as an author, distinct from the individual authors. Group authors may also be known as Collaborative-, Corporate- or Collective-authors. Group-authors would include individuals who contributed to the research that led to the abstract but are not named individually as authors. A common example in dental research would be a practice-based research network. Group-authorship is not meant to acknowledge the University, Institution or Corporation under whose auspices the research was conducted. If your abstract does have a Group-author that includes individuals who contributed to the research that led to the abstract but are not named individually as authors, the name of the Group-author must be added along with the City, State and Country for each individual person. The Group-author listings will be included in the Author/Co-author Index online and the Program Book.

The Group-author Abstracts section of the abstract submission system should not be used to list individual co-authors.

  • Always hyphenate when possible (e.g., use “composite-resin restorations”, rather than “composite resin restorations”), and string together complicated phrases with hyphens.
  • Abbreviate extensively [i.e., introduce abbreviations quickly and use them. Do not say hybrid zone but rather introduce hybrid zone (HZ) and then use HZ from that point onward].
  • Always close spaces between numbers and units (e.g., instead of 30 mm, say 30-mm or 30mm; never leave spaces between numbers & standard deviations; and replace “30 ± 5” with “30±5”).
  • Always use tables for the presentation of information when possible. Put units in headers and omit them from the rest of the matrix.
  • Make sure that there is no inadvertent ‘dangling punctuation’ in the text, such as a comma or period that is not immediately adjacent to a word.
  • Eliminate as many “articles” (a, an, the, …) as possible.
  • String together all of the steps in the Materials & Methods section so that you are not starting and stopping individual sentences with separate subjects, verbs, and adjectives [e.g., “The samples (n=10/gp) were etched (37% H3POO4), washed (15s), stored (37°C, 7d), conditioned (25°C, 10m), tested (0.1mm/m), and statistically analysed (ANOVA, Tukey’s, p<0.05).”].
  • Replace statements with equations [e.g., Instead of “10 samples were tested for each group” insert “(n=10)” into an appropriate sentence].
  • Report all statistical differences with superscripts on results that can be attached rather than requiring separate statements.
  • Construct tables to minimize the number of necessary cells.

If you have any special requests (i.e., religious, academic, travel or personal conflicts) or if you wish to request that abstracts be scheduled in a specific order, please enter this information in the “Special Request” box when entering your abstract online. IADR will not change your presentation if you neglect to include any details regarding your request when submitting your abstract. If you book your travel arrangements prior to receiving your abstracts notification email, please book your return flight for the end of the meeting (late Saturday, November 30th, 2019). IADR will NOT change presentation dates/times to accommodate your travel schedule or requests made after submission.

Please note that it may not be possible to accommodate all special requests but the Group Program Chair will do their best when scheduling the abstracts.



Presentations will be selected for the program on the basis of the scientific quality of the work as judged from the abstract. An impartial panel of reviewers will evaluate the content of each abstract. Selection of the abstracts will be made by these reviewers and by the ASC, whose decision is final.

The following are the evaluation criteria used in the review of abstracts. This is provided to call your attention to points that will be considered. In the final analysis, it will be the reviewers’ judgment of the value of any abstract that will determine whether the abstract should appear on the program. Since the abstracts are published and become part of the world’s scientific literature, it is important that the content be scientifically sound and grammatically correct.

Each abstract is reviewed so that high standards can be ensured.


Common reasons for rejection are:

  1. Abstract is not original research.
  2. The research is not innovative in its approach to the stated problem (methodology or data collection or analysis or data interpretation).
  3. Nature of problem not explicit from either title or abstract.
  4. Material too closely related to another abstract submitted by the same co-authors; should have been combined into a single paper.
  5. Abstract has been presented at other meeting(s) or previously published.
  6. Abstract poorly organized and/or not complete. Required information not given in abstract:
    • Objective
    • Methods
    • Results – data and statistical analysis, or
    • Conclusions
  7. Methods of obtaining data not appropriate with respect to the stated problem for the following reasons:
    • Methods not sufficiently precise to permit the measurements to be accurate, i.e., variations are within the error limits for the method.
    • Sampling method contains inherent discriminatory factors not recognized.
    • Size of sample insufficient to show significant conformity or variables.
    • No well-defined criteria given for evaluation of variables.
    • Choice of controls questionable.
    • No control groups reported.
    • Significance of results related to the nature of the problem being studied is not stated.
  8. Conclusions do not necessarily follow as a consequence of the method of analysis applied to the data.
  9. Conclusions not adequately qualified, i.e., conclusions have greater limitations than implied by the author.
  10. Correlations suggested may be fortuitous insofar as no plausible cause-and-effect relation has been suggested, and none is obvious.
  11. Abstract is not in English. 
  12. Abstract is over word limit.



Behavioral, Epidemiologic and Health Services Research

Abstracts should be submitted to this category if they are related to behavioral studies and other studies involving pain and anxiety, utilization of dental services, professional education, provision of care, clinical decision analysis, cost-effectiveness analysis, comparative- effectiveness research, reimbursement mechanisms or delivery systems and their effect on oral health. Studies that address the following topics are also appropriate: anthropology, psychology, sociology, health education and promotion, economics, finance and public health. Check the “epidemiological methods” box for papers that include important and timely issues pertaining to the design and conduct of human research studies. Descriptive epidemiology papers should be submitted to the Group corresponding to the topic area of the abstract.

Cariology Research

Abstracts should be submitted to this category if they are related to dental caries or dental erosion — specifically their etiology, prevention, diagnosis and treatment. Research approaches could include: epidemiology, clinical studies, or laboratory and animal experimentation. Studies that are concerned with caries, but where the major emphasis is related to microbiology, salivary glands or dental materials, should be considered by those particular Groups. The following submission options will be available: Demin/Remineralization; Erosion; Fluoride and Ca-based Products; Detection, Risk Assessment and Others; Microbiological Studies/Biofilm; and Clinical and Epidemiological Studies.

Craniofacial Biology

Abstracts should be submitted to this category if they are related to a broad array of basic science and clinical studies dealing with the normal growth, development and maintenance of the craniofacial tissues and the consequences of physiological and pathological variations and challenges on these processes.

Dental Materials

All scientific aspects of dental materials are appropriate for this category. This includes laboratory, clinical, and animal testing of materials and their components, as well as instruments and equipment. The interactions of materials and the oral environment are also included. The development of new materials, testing methods, and protocols is of particular interest. applied to materials.

Education Research

Abstracts should be submitted to this category if they are related to research affecting all facets of education in the field of dentistry and oral health. Areas include but are not limited to: educational practice; teaching and learning dynamics; teaching evaluation, curriculum design, program evaluation, and outcomes evaluation at all levels (professional and public); competency evaluation (validity and reliability); applications of new technologies, methodologies, teaching and research approaches, characteristics of institutions, educators, and students, licensing and certification, quality assurance, continuing competence, and professional development, as well as cross-professional interaction.

Geriatric Oral Research

Abstracts should be submitted to this category if they are related to research in the basic mechanisms of aging, the prevalence and characteristics of diseases and disorders in the aged, and their prevention and treatment. This includes general biomedical research, oral medicine, patient management, clinical techniques, and delivery systems, as well as the psycho-social and economic aspects of treating the older adult.

Implantology Research

Abstracts should be submitted to this category if they are related to the basic and clinical science aspects of the implantation of materials and/or biological analogues into the orofacial complex for the augmentation, replacement, or regeneration of body tissues, excluding tooth restoration. The properties of both the natural tissues being replaced and the synthetic/biological substitutes are of interest. The subject area includes: structural and property studies on natural and synthetic materials, biological investigation, tissue/material interfaces, and systematic clinical evaluation of implant materials and designs.


Abstracts should be submitted to this category if they are related to microbiology/immunology, including: micro-organisms, such as bacteria, viruses, fungi, protozoa, etc., and their relationship to and/or association with oral diseases; microbial pathogenesis; microbial biofilms; microbial genetics, gene structure, gene expression and regulation, genomics, and proteomics; microbial physiology and the by-products of micro-organisms and their relationship to oral diseases; the effects of chemicals, antimicrobial agents, etc., on the physiology and virulence of oral micro-organisms; the serologic and immunologic aspects of oral diseases (human immunologic response to oral micro-organisms); the systemic effects of oral organisms; oral manifestations of systemic diseases; and cell biology and tissue culture studies (excluding experimental pathology) as they relate to oral micro- organisms and diseases. Infection Control: This area includes research covering all aspects of infectious disease transmission and control in the context of oral health care and its delivery in any setting, including the dental office, laboratory, and hospital. Presentations may include assessments of transmission potential and risk, methods of disease spread, or techniques for prevention of cross-infection arising from any source, such as person-to-person contact or via fomites or aerosols.

Mineralized Tissue

Abstracts should be submitted to this category if they are related to research principally directed toward elucidation of some aspects of hard-tissue structure, formations or function. While overlap between research in this area and that of cariology, periodontology and/or salivary research may frequently occur, distinction should be made on the basis of the primary goal of the research. The following session topics should aid you in determining whether a research topic is appropriate for this area: formation of calcium phosphates; regulation of mineralization and dissolution; fluoride; development and mineralization; matrix constituents; regulatory factors in bone resorption; regulatory factors in cell culture; ultrastructure and morphology; and morphology, physiology, and chemistry.

Oral & Maxillofacial Surgery

Abstracts should be submitted to this category if they are related to basic and applied research dealing with the surgical and non-surgical management of: impacted teeth; residual ridge deformities and their reconstruction with grafts, alloplasts, and implants; dentofacial and craniofacial deformities; temporomandibular joint dysfunction; hard- and soft-tissue trauma; benign and malignant diseases of the soft and hard tissues, including salivary glands; reconstruction of soft- and hard-tissue defects; infection of the face, head, and neck; nerve dysfunction; post-surgical pain and swelling; and wound healing and factors which affect it, as well as long-term follow-up data on research done in any of these areas.

Oral Medicine & Pathology

Abstracts should be submitted to this category if they are related to experimental investigation of diseases affecting the oral cavity and the adjacent tissues, but excluding those (e.g., periodontal disease, caries, salivary research) more appropriately dealt with by other Groups. Experimental investigations of normal structure are appropriate insofar as they contribute to our understanding of disease, and cell, tissue, and organ cultures are also included in this category. Epidemiological, clinical and laboratory research are encouraged.

Orthodontics Research

Abstracts should be submitted to this category if they are related to any aspect of orthodontics field including Clinical, Materials & Appliances, Basic Science, and Translational Research.

Pediatric Oral Health Research

Abstracts should be submitted to this category if they are related to pediatric oral health research and report results of clinical, survey, in vitro, genetic, health services and qualitative studies related to pediatric/children’s oral health. This includes but isn’t not limited to cariology, pulp therapy in children, behavioral factors and study population characteristics of participants under 18 years of age, and caregivers of children.

Periodontal Research

Abstracts should be submitted to this category if they are related to periodontal and peri- implant tissues, epidemiology and diagnosis of periodontal diseases and peri-implant biological complications, etiological factors/microbiology, pathogenesis, of periodontal diseases and peri-implant biological complications, preclinical in vivo experiments and clinical trials to evaluate treatment of periodontal diseases and peri-implant biological complications, chemoprevention and chemotherapeutic approaches, patient reported outcome measures related to diseases of the periodontium and peri-implant tissues and their treatment.

Prosthodontics Research

Abstracts should be submitted to this category if they are related to prosthodontics research and includes the following: fixed prosthodontics, removable prosthodontics, materials as they relate to prosthodontics in general, occlusion, TMJ research, implants, electromyography, basic and clinical applications to restorative dentistry in general, electrosurgery, ceramics and acid-etch restorative dentistry.

Pulp Biology & Regeneration Research

Abstracts should be submitted to this category if they are related to studies on the development, structure, and function of the dental pulp, the dentin-pulp complex and related periapical tissues. Studies may include methods in the following areas of analysis: autoradiography, radiography, molecular biology, protein chemistry (genomics and proteomics), microbiology, immunology, physiology, biochemistry and pharmacotherapeutics. Physiological and pathological processes involving these tissues include: signaling mechanisms in tooth development, dentinogenesis and dentin matrix proteins, wound healing and regeneration, as well as neural, vascular, and cellular responses to anesthesia, pain-producing stimuli, materials and instrumentation used in the restoration of teeth and hereditary diseases. Also included are those related areas of clinical research pertaining to dentin and pulpal tissues from disciplines such as endodontics, pediatric dentistry, restorative dentistry (e.g., pulpal compatibility testing of dental restorative materials), periodontics (e.g., root dentin hypersensitivity) and oral and maxillofacial surgery.

Salivary Research

Abstracts should be submitted to this category if they are related to the morphology, biochemistry, physiology, endocrinology, development and pathology of salivary glands; the composition, secretion, and functions of saliva; and the synthesis of salivary components. It may also include the effects of saliva on oral structures and micro-organisms—especially dental plaque and calculus—and the influence of such effects on oral pathological conditions—such as dental caries, periodontitis, mucositis and ulcers—provided there is sufficient emphasis on the salivary factors.

Stem Cell Biology

Abstracts should be submitted to this category if they promote and encourage investigation into stem cell biology, particularly in relevance to orofacial stem/progenitor cells. Abstract subjects should promote and encourage the development of stem cell therapies for the regeneration of orofacial tissues. Abstracts should provide an international and cooperative forum for the discussion of stem cell biology and regenerative dental medicine. Submitted abstracts should further promote translational approaches of stem cell biology into novel or enhanced approaches that benefit the health of patients who suffer from dental, oral and craniofacial diseases.



The official notifications will be emailed on 7 August 2019 to all accepted presenters. A further notification will be sent on 21 August with your presentation date, session time and presentation guidelines.

PLEASE NOTE: All communication between IADR and the presenter will take place via email. The email address used will be the one supplied when submitting the abstract for the PRESENTING AUTHOR. Please make sure that you enter a valid, long-term email address for the PRESENTING AUTHOR so that you will receive all important notices that are sent from IADR regarding your abstract and presentation at the meeting.



All presenters are required to pre-register for the meeting by the presenter pre-registration deadline of 28 August 2019. Failure to pre-register by this date will result in the withdrawal of your submission. Please plan accordingly. Also, if you plan to register at the IADR member rate, please make every attempt to complete your annual membership renewal in advance of the presenter pre-registration deadline to allow ample processing time.



At the time of submission, you will be asked to select your preferred mode of presentation. However, not all requests can be accommodated and the final mode of your presentation will be selected by the Scientific Program Committee.

Every effort will be made to honour poster only presentation requests. The IADR-APR 2019 Meeting will include presentations in the following mod

Oral Presentation:

  • Up to six individual oral presentations in a meeting room.
  • PowerPoint Presentations (all equipment provided).
  • Presentations last 10 minutes; discussion after each presentation lasts five minutes.
  • Two Session Chairs facilitate the session.

Poster Presentation:

  • Presented on a poster board
  • Posters will be available for viewing all day on Thursday, Friday or Saturday.
  • No audio-visual equipment is used.
  • Session Chairs will be assigned to facilitate the session.


Frequently Asked Questions
  1. Do I need to be a member of IADR to submit an abstract? However, you do need to be a member in order to be eligible for some awards/competitions. You will also receive a reduced registration rate as a member of IADR. Your membership must be paid for 2019 in order to be eligible for the reduced member pricing.
  2. How do I know if my abstract was successfully received? If there are any incomplete steps, you will not be able to submit your abstract. You will be able to view a proof of your abstract when you click on the Submit button. You will also receive a confirmation email from the system following successful submission of your abstract.
  3. Is there a word limit imposed on abstract titles? Yes, all abstract titles must be 10 words or less.
  4. Is there a word limit imposed on abstract text? Yes, all abstract text must be composed of 300 words or fewer.
  5. Can I change my Scientific Group/Network to a different group after I complete my submission? Yes, you may return to your submission at any time prior to the abstract submission deadline to amend and edit the Scientific Group/Network. Be sure to save your changes and resubmit your abstract. Draft abstracts will not be reviewed.
  6. What is the abstract deadline? Monday, 1 July 2019 (11:59 p.m. AEST).
  7. Can I make changes to my abstract text after the deadline? IADR does not permit modifications to abstract text after the deadline under any circumstances. It is very important that you submit an error free abstract text.
  8. If I forget to add an author, can I do so after the abstract deadline? Yes, you can still add an author if necessary by emailing the Meetings Managers. However, please make every attempt to add all authors during the abstract submission text.
  9. Can I submit more than one abstract (excluding session proposals/keynotes) as an abstract presenter? IADR permits authors to submit one abstract only as a presenting author. You may be listed as a co-author on more than one abstract. If you submit more than one abstract as a presenter, you will be asked to delete one of the submissions. If your response is not received, one of the submissions will be automatically deleted and will not be reviewed.
  10. When I submit my abstract, how do I indicate my mode preference? You will be asked to submit your presentation mode preference at the time of submission (oral or poster). IADR makes every attempt to provide you with your first choice, but there is no guarantee as a number of programming factors must be taken into account during the programme finalisation process. The Scientific Program Committee makes the final decision regarding presentation mode.
  11. Should I put the abstract title, authors and affiliations in the text of my abstract? These items will be collected separately during the abstract submission process. References are not collected.
  12. Is there a limit on the number of co-authors that I can add to my abstract? No.
  13. Can I submit previously published or presented work? No, all abstracts must be original research. Abstracts cannot be submitted if the research represented by the abstract will be published (online or in print) and/or presented at any other national or international meeting prior to 28 November 2019.
  14. If I make a mistake during the abstract submission process, do I need to start a new submission? You can make changes to your abstract submission at any time prior to the deadline by logging into your eOrganiser Account and selecting to Edit button. Be sure to save your changes and resubmit your abstracts.
  15. Will IADR edit my abstract? Once you submit your abstract, it will not be edited in any way for content. Typographical or grammatical errors that appear in your abstract submission will also appear in the final online Scientific Program. Abstracts may be formatted only to follow IADR publication guidelines or requirements.